Lupin Digital Health CEO Sidharth Srinivasan Explores the Transformative Impact of Digital Therapeutics

Written By :  Dr. Nandita Mohan
Written By :  Sidharth Srinivasan
Published On 2024-03-09 15:53 GMT   |   Update On 2024-04-10 08:46 GMT
Advertisement

India Live 2024 , the paramount global cardiology event hosted by the Interventional Cardiology Foundation of India, focused on Interventional Cardiology: enabling quality outcomes for heart disease patients.

Amidst this backdrop, Lupin Digital Health and the American College of Cardiology (ACC) announced a pioneering collaboration to introduce Digital Therapeutics (DTx) in India, aimed at delivering in-home cardiovascular care.
Their flagship product, Lyfe, launched just a year ago, represents a groundbreaking digital therapeutic solution designed to monitor and manage acute coronary syndrome (ACS) patients using advanced technologies.
In our conversation, with Mr. Sidharth Srinivasan, CEO of Lupin Digital Health, share insights on the transformative power of digital therapeutics. He discussed how Lupin Digital Health revolutionized healthcare in India by leveraging DTx and Remote Patient Monitoring to improve outcomes and reduce rehospitalization rates and explored the potential and challenges of digital therapeutics in reshaping cardiac care in India.


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News